General Information of the Compound
| Compound ID |
CP0522121
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-((5-cyclohexyl-3-(4-(trifluoromethoxy)phenyl)-1H-pyrazol-1-yl)methyl)-N-(2H-tetrazol-5-yl)benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H24F3N7O2
|
||||||||||||||||||
| Molecular Weight |
511.508
|
||||||||||||||||||
| Canonical SMILES |
FC(F)(F)Oc1ccc(cc1)-c1cc(C2CCCCC2)n(Cc2ccc(cc2)C(=O)Nc2nnn[nH]2)n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H24F3N7O2/c26-25(27,28)37-20-12-10-17(11-13-20)21-14-22(18-4-2-1-3-5-18)35(32-21)15-16-6-8-19(9-7-16)23(36)29-24-30-33-34-31-24/h6-14,18H,1-5,15H2,(H2,29,30,31,33,34,36)
Show/Hide
|
||||||||||||||||||
| InChIKey |
WQWMRDGYOCXAEA-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02242, Gastric inhibitory polypeptide receptor
Protein ID: PT01473, Glucagon receptor